The Lockerbie Bomber’s Final Lesson

By: George Noga


In May of this year Abdel al-Megrahi, a.k.a. the Lockerbie Bomber, departed this earth and none too soon for his victims and their families.

He was released from a Scottish prison in 2009 purportedly for compassionate reasons and allegedly with less than three months to live. The real reason for his release was Gordon Brown’s shameful lust for Libyan oil and trade. Surprisingly, it turns out Megrahi’s release contained a final and valuable unintended lesson.

“Surprisingly, Megrahi’s release contained
a final and valuable unintended lesson.”

Scottish National Health Service (“NHS”) cancer specialists who treated Megrahi correctly concluded he had less than three months to live according to NHS treatment protocols for prostate cancer.

A decade ago (2003) Taxotere, a new chemotherapy drug for prostate cancer, was found to significantly improve survival and quality of life. In 2005 the Scottish rationing board acknowledged the proven benefits of Taxotere but nonetheless concluded that its “cost effectiveness has not been demonstrated”.

George Noga

Later, the rationing board for the entire UK modified this ruling but continued to severely ration Taxotere, limiting its use only to a few highly specific circumstances – which did not include Megrahi.

When  Megrahi returned to Libya he immediately received advanced chemotherapy treatment likely including Taxotere. He also received radiation treatments. Moreover, he was given Abiraterone, a new drug approved by the FDA in 2011. Unsurprisingly, the Scottish rationing board insisted Abiraterone also was not cost effective and prohibited its use by NHS.

Nothing Megrahi did can blot out even an infinitesimal amount of the evil he promulgated. However unintended it was, Megrahi reinforced a lesson all of us should long ago have absorbed, i.e. socialized health care is vastly inferior in terms of both saving and prolonging life and also in maintaining patients’ quality of life. Patients receive better care in Tripoli than in Glasgow for crying out loud. Let’s summarize.

“Upstanding UK citizens receive care
vastly inferior  to a terrorist in Libya.”

  • Megrahi’s life expectancy was not misdiagnosed; shamefully, it was accurate under the protocols extant in the UK. Of course, either way it reflects discredit on the NHS.
  • The most compassionate act Megrahi received was being freed from the NHS.
  • In the UK the Lockerbie Bomber’s survival was 3 months; in Libya it was 3 years – an improvement of twelve fold, or 1,200%. If Megrahi had gone to Libya sooner, he might have lived even longer, or perhaps even beat the cancer entirely.
  • In 2012 Scotland, Taxotere is only rarely available and Abiraterone is disapproved.

For Gordon Brown and his Labour government to release the Lockerbie Bomber while lying about the real reason is a scandal majeure – but it is not the biggest scandal. The far bigger scandal is that law abiding UK citizens receive vastly inferior care to that of a terrorist in Libya.

This rightly should make Americans terrified of socialized medicine and the inevitable rationing boards it spawns. The Lockerbie Bomber imparted a final lesson; will we learn from it?

/

Please Support Citizen Journalism!

DONATE TO BIZPAC REVIEW

Please help us! If you are fed up with letting radical big tech execs, phony fact-checkers, tyrannical liberals and a lying mainstream media have unprecedented power over your news please consider making a donation to BPR to help us fight them. Now is the time. Truth has never been more critical!

Success! Thank you for donating. Please share BPR content to help combat the lies.

Comment

We have no tolerance for comments containing violence, racism, profanity, vulgarity, doxing, or discourteous behavior. If a comment is spam, instead of replying to it please click the ∨ icon below and to the right of that comment. Thank you for partnering with us to maintain fruitful conversation.

BPR INSIDER COMMENTS

Scroll down for non-member comments or join our insider conversations by becoming a member. We'd love to have you!

Latest Articles